TY - BOOK
T1 - Synthesis of bicyclic alkaloids from the iridoid antirrhinoside
AU - Frederiksen, Signe Maria
PY - 1999
Y1 - 1999
N2 - The present thesis describes the isolation of the iridoid
glucoside antirrhinoside from Antirrhinum majus, and the
approaches made towards its transformation into analogues of
biologically active compounds, with special interest in syntheses
of bicyclic alkaloids.A synthetic piperidine monoterpene alkaloid
was prepared from antirrhinoside by means of an enzymatic cleavage
to afford the aglucone, followed by a double reductive amination
with benzylamine hydrochloride and sodium cyanoborohydride. The
resulting piperidine was modified by opening of the epoxide on the
cyclopropane ring by azide or by reduction using lithium aluminum
hydride. The piperidines were subjected to hydrogenation to remove
the N-benzyl group. The compounds were tested for hypoglycaemic
activity by Novo Nordisk, but no activity was observed.Another
approach towards a synthetic piperidine monoterpene was attempted.
The strategy involved preparation of a diol, which through
treatment of its ditosyl derivative with an amine would afford a
piperidine monoterpene. Antirrhinoside was protected as its
5,6-O-monoacetonide via its 5,6:4',6'-O-diacetonide. The
5,6-O-isopropylidene-derivative was hydrogenated to give the
3,4-dihydro-analogue and enzymatically cleaved by b-glucosidase to
afford the 3,4-dihydro-5,6-O-isopropylidene antirrhinoside
aglucone. Unfortunately, the subsequent sodium borohydride
reduction of the aglucone proved difficult, affording a mixture of
the expected diol and a product with a 2-oxo[3.2.1]octane
framework. The latter strategy was therefore abandoned.A one-pot
reaction involving ozonolysis and subsequent reduction of the
5,6-O-isopropylidene-2',3',4',6'-tetra-O-acetyl antirrhinoside
yielded a diol, which was considered a potential intermediate in
the preparation of enantiopure 3-azabicyclo[3.3.0]octane
alkaloids. The corresponding ditosyl derivative was treated with
benzylamine to afford a bicyclic N-benzylated pyrrolidine. An
alternative starting material was prepared from
5,6:4',6'-di-O-isopropylidene antirrhinoside by reduction with
lithium aluminum hydride. Subsequent ozonolysis and sodium
borohydride gave the expected triol. The corresponding ditosyl
derivative was treated with benzylamine or 2-methoxy-benzylamine
to afford bicyclic pyrrolidines in 54-66% yield. The
isopropylidene protection was removed and the unprotected
pyrrolidine was acylated with benzoyl chloride to afford a
potential Substance P antagonist.In addition antirrhinoside has
been used as starting material for preparation of a new isolate
from Antirrhinum majus. The 3,4-dihydro-5,6-O-isopropylidene
antirrhinoside aglucone was oxidised with RuO4 and treated with
triethylamine to afford a 5,6-O-isopropylidene lactone. The
isopropylidene protection was removed to afford a lactone, which
proved to be identical to the natural product. Preparation of the
known pyrrolidine 2,5-dideoxy-2,5-imino-D-glucitol (DGDP) was
accomplished from L-gulono-1,4-lactone through an 11 step
synthesis. This work was performed during a stay at The Dyson
Perrins Laboratory, Oxford University and it is described at the
end of this thesis as a separate study.
AB - The present thesis describes the isolation of the iridoid
glucoside antirrhinoside from Antirrhinum majus, and the
approaches made towards its transformation into analogues of
biologically active compounds, with special interest in syntheses
of bicyclic alkaloids.A synthetic piperidine monoterpene alkaloid
was prepared from antirrhinoside by means of an enzymatic cleavage
to afford the aglucone, followed by a double reductive amination
with benzylamine hydrochloride and sodium cyanoborohydride. The
resulting piperidine was modified by opening of the epoxide on the
cyclopropane ring by azide or by reduction using lithium aluminum
hydride. The piperidines were subjected to hydrogenation to remove
the N-benzyl group. The compounds were tested for hypoglycaemic
activity by Novo Nordisk, but no activity was observed.Another
approach towards a synthetic piperidine monoterpene was attempted.
The strategy involved preparation of a diol, which through
treatment of its ditosyl derivative with an amine would afford a
piperidine monoterpene. Antirrhinoside was protected as its
5,6-O-monoacetonide via its 5,6:4',6'-O-diacetonide. The
5,6-O-isopropylidene-derivative was hydrogenated to give the
3,4-dihydro-analogue and enzymatically cleaved by b-glucosidase to
afford the 3,4-dihydro-5,6-O-isopropylidene antirrhinoside
aglucone. Unfortunately, the subsequent sodium borohydride
reduction of the aglucone proved difficult, affording a mixture of
the expected diol and a product with a 2-oxo[3.2.1]octane
framework. The latter strategy was therefore abandoned.A one-pot
reaction involving ozonolysis and subsequent reduction of the
5,6-O-isopropylidene-2',3',4',6'-tetra-O-acetyl antirrhinoside
yielded a diol, which was considered a potential intermediate in
the preparation of enantiopure 3-azabicyclo[3.3.0]octane
alkaloids. The corresponding ditosyl derivative was treated with
benzylamine to afford a bicyclic N-benzylated pyrrolidine. An
alternative starting material was prepared from
5,6:4',6'-di-O-isopropylidene antirrhinoside by reduction with
lithium aluminum hydride. Subsequent ozonolysis and sodium
borohydride gave the expected triol. The corresponding ditosyl
derivative was treated with benzylamine or 2-methoxy-benzylamine
to afford bicyclic pyrrolidines in 54-66% yield. The
isopropylidene protection was removed and the unprotected
pyrrolidine was acylated with benzoyl chloride to afford a
potential Substance P antagonist.In addition antirrhinoside has
been used as starting material for preparation of a new isolate
from Antirrhinum majus. The 3,4-dihydro-5,6-O-isopropylidene
antirrhinoside aglucone was oxidised with RuO4 and treated with
triethylamine to afford a 5,6-O-isopropylidene lactone. The
isopropylidene protection was removed to afford a lactone, which
proved to be identical to the natural product. Preparation of the
known pyrrolidine 2,5-dideoxy-2,5-imino-D-glucitol (DGDP) was
accomplished from L-gulono-1,4-lactone through an 11 step
synthesis. This work was performed during a stay at The Dyson
Perrins Laboratory, Oxford University and it is described at the
end of this thesis as a separate study.
M3 - Book
BT - Synthesis of bicyclic alkaloids from the iridoid antirrhinoside
PB - Ph. d. Report, DTU
CY - Lyngby
ER -